Key facts
- DAYLI Partners is a venture capital firm based in Seoul, South Korea with 34 tracked portfolio companies.
- Notable positions include PhAST, BreezeBio, Alodokter, Elisigen, Galux.
About DAYLI Partners
Founded in 2018, DAYLI Partners is a venture capital firm based in Seoul, South Korea. The firm seeks to invest in healthcare, therapeutics, life sciences, medical devices, diagnostics, and fintech sectors.
Free account
See the whole book
- ·The book's top 25 — of 34 recorded positions
- ·Watchlist + alerts for DAYLI Partners's activity
Create free account
No card required
Portfolio, priced
34 companies · by our current valuations| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| PhAST | — | $241.7M | — | |
| BreezeBio | — | $234.0M | — | |
| Alodokter | — | $144.1M | — | |
| Elisigen | — | $74.5M | — | |
| Galux | — | $67.8M | — | |
| Novelty Nobility | — | $10.8M | — | |
| Dr.Diary | — | — | — | |
| MediFab | — | — | — | |
| Doctor Now | — | — | — | |
| Idience | — | — | — | |
| Kanaph Therapeutics (KRX: 0082N0) | — | — | — | |
| Curaum | — | — | — | |
| Ubix Therapeutics | — | — | — | |
| Txinno Bioscience | — | — | — | |
| G2e | — | — | — | |
| + 19 more companies · a free account shows the top of the book | ||||
Frequently asked
- What companies does DAYLI Partners invest in?
- DAYLI Partners has 34 recorded portfolio companies, including PhAST, BreezeBio, Alodokter, Elisigen.